Elanco Animal Health (ELAN) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
26 Oct, 2026Executive summary
Annual meeting scheduled for May 16, 2025, at 8:00 AM EDT, virtually; voting deadline is May 15, 2025, at 11:59 PM ET.
Voting matters and shareholder proposals
Ballot includes auditor ratification, an advisory vote on named executive officer compensation, and an advisory vote on say-on-pay frequency.
Board of directors and corporate governance
Directors Kapila Anand and Paul Herendeen are nominees; the board recommends voting For both.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Elanco Animal Health
- 2027 growth confidence rests on innovation, pricing and sustained margin expansion.ELAN
UBS Global Healthcare Conference - Innovation-led growth lifted Q3 earnings and prompted higher FY2026 guidance.ELANQ3 2026
- Strong innovation, margin expansion, and global rollout drive sustained growth outlook.ELANBank of America Global Healthcare Conference
- Innovation-led growth and expanding product adoption drive strong outlook through 2027.ELANMorgan Stanley 24th Annual Global Healthcare Conference
- Q2 2026 saw double-digit revenue growth, margin expansion, and raised full-year guidance.ELANQ2 2026
- Innovation and operational efficiency drive growth and margin expansion across pet and farm segments.ELANPiper Sandler 37th Annual Healthcare Conference
- Q1 2025 saw 4% organic growth, raised guidance, and accelerated debt paydown on strong innovation.ELANQ1 2025
- Blockbuster launches and innovation pipeline drive strong growth and sustainability in 2025.ELAN43rd Annual J.P. Morgan Healthcare Conference 2025
- 2024 saw organic growth, margin gains, and debt reduction; 2025 targets innovation-led expansion.ELANQ4 2024